A study comparing the effectiveness of single burr hole of the skull with double burr hole of the skull in the management of chronic subdural haemorrhage

A randomized controlled trial comparing the efficacy of single burr hole with double burr hole in the patients of chronic subdural hematoma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN53688663

Enrollment

Registered

2025-04-24

Start date

2023-07-01

Completion date

Unknown

Last updated

2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic subdural hematoma Circulatory System

Interventions

Participants were randomised by simple randomisation into two groups: Group A: Double burr hole (frontal and parietal) Group B: Single burr hole (parietal) Radiological assessment (NCCT BRAIN) was do

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All diagnosed cases of chronic subdural hematoma

Exclusion criteria

Exclusion criteria: 1. Patients with recurrent chronic subdural hematoma (cSDH) 2. Patients with asymptomatic chronic subdural hematoma (cSDH) 3. Patients with hematological disorders or those using anticoagulant drugs 4. Patients with septated membranes in chronic subdural hematoma (cSDH) 5. Patients with acute on chronic subdural hematoma (SDH)

Design outcomes

Primary

Measure	Time frame
1. Post-operative complications assessed at 6 hours, 1 week and 1 month post-intervention 2. Surgical site infection assessed using CDC criteria at 6 hours, 1 week and 1 month post-intervention 3. Persistence of headache assessed using the Headache Impact Test (HIT-6) at 1 month 4. Neurological deficit assessed using the Glasgow Coma Scale (GCS) at 1 month 5. Level of consciousness assessed using the Glasgow Coma Scale (GCS) at 1 month	—

Measure

Time frame

1. Post-operative complications assessed at 6 hours, 1 week and 1 month post-intervention 2. Surgical site infection assessed using CDC criteria at 6 hours, 1 week and 1 month post-intervention 3. Persistence of headache assessed using the Headache Impact Test (HIT-6) at 1 month 4. Neurological deficit assessed using the Glasgow Coma Scale (GCS) at 1 month 5. Level of consciousness assessed using the Glasgow Coma Scale (GCS) at 1 month

—

Secondary

Measure	Time frame
1. ICU length of stay measured using patients' medical records 2. Hospital length of stay measured using patients' medical records	—

Countries

India

Contacts

Public ContactDeepak Kumar

id-deepak10890@aiimspatna.org+91 (0)7991190620

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: May 30, 2026